INR 1594.3
(-3.42%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 18.87 Million INR | -70.52% |
2022 | 64 Million INR | -79.72% |
2021 | 315.59 Million INR | -45.48% |
2020 | 578.83 Million INR | 50.49% |
2019 | 384.63 Million INR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | - INR | 0.0% |
2023 Q4 | 18.87 Million INR | 0.0% |
2023 FY | 18.87 Million INR | -70.52% |
2023 Q2 | 26.71 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 Q3 | - INR | -100.0% |
2022 Q4 | 64 Million INR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Biocon Limited | 129.32 Billion INR | 99.985% |
Blue Jet Healthcare Limited | 3.79 Million INR | -397.889% |
Dishman Carbogen Amcis Limited | 2.45 Billion INR | 99.232% |
Jubilant Ingrevia Limited | 4.25 Billion INR | 99.557% |
Lyka Labs Limited | 429.06 Million INR | 95.602% |
Panacea Biotec Limited | 209.9 Million INR | 91.01% |
Piramal Pharma Limited | 24.83 Billion INR | 99.924% |
SMS Lifesciences India Limited | 331.45 Million INR | 94.307% |
Supriya Lifescience Limited | 50.2 Million INR | 62.41% |
Syngene International Limited | 1 Billion INR | 98.113% |
TAKE Solutions Limited | 7.5 Million INR | -151.6% |
Zota Health Care Limited | 631.64 Million INR | 97.013% |